SCHEMBL31239104

SCHEMBL31239104

CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(N)=O

nearest known ligand 0.58

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NMUR2 Q9GZQ4 9/20 0.58
▸ NMUR1 Q9HB89 8/20 0.54
▸ NTSR1 P30989 2/20 0.52
▸ NTSR2 O95665 1/20 0.52
▸ OPRM1 P35372 3/20 0.49
▸ OPRK1 P41145 3/20 0.49
▸ OPRD1 P41143 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31239147 0.96 NMUR2 (0.56) NMUR2NMUR1NTSR1OPRM1OPRK1
SCHEMBL31239130 0.96 NMUR2 (0.55) NMUR2NMUR1NTSR1NTSR2OPRM1
SCHEMBL31239092 0.94 NMUR2 (0.57) NMUR2NMUR1NTSR1NTSR2
SCHEMBL31239093 0.91 NMUR2 (0.58) NMUR2NMUR1OPRM1OPRK1
SCHEMBL31239042 0.89 NTSR1 (0.58) NMUR2NMUR1NTSR1NTSR2OPRM1
SCHEMBL31267154 0.83 NMUR2 (0.61) NMUR2NMUR1NTSR1NTSR2
SCHEMBL29657973 0.83 SLC6A2 (0.60) NMUR2NMUR1NTSR1NTSR2OPRM1
SCHEMBL30751612 0.82 CALCR (0.54) NTSR1NTSR2OPRM1OPRK1OPRD1
SCHEMBL30444466 0.82 NMUR2 (0.59) NMUR2NMUR1NTSR1NTSR2
SCHEMBL1661256 0.81 NMUR2 (0.54) NMUR2NMUR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119039391-B High affinity peptide of targeted trophoblast fine antigen 2 and application thereof 中国科学院基础医学与肿瘤研究所(筹) 2025-02-25 — — CN disclosed
CN-119039391-A High affinity peptide of targeted trophoblast fine antigen 2 and application thereof 中国科学院基础医学与肿瘤研究所(筹) 2024-11-29 — — CN disclosed
Send feedback